Connect with us

International

Grain Markets: Farmers Eye Weather, War as Growing Season Starts

Midwest farmers experienced a wet spring, resulting in the slowest corn planting pace in 9 years. Now they must manage the risks of an unpredictable growing…

Published

on

Midwest farmers experienced a wet spring, resulting in the slowest corn planting pace in 9 years. Now they must manage the risks of an unpredictable growing season.

U.S. farmers navigating an unusual combination of risks and surprises in 2022 – including war, pandemic, and soaring inflation – now find themselves staring down the risk factor that’s always been there: weather.

A cold, wet April and May in the Midwest kept many farmers out of their fields for extended periods, resulting in the slowest corn planting pace in nine years. Adverse weather casts even greater uncertainty on acreage, production, and price outlooks for the two biggest U.S. crops and could further unsettle global markets already roiled by Russia’s invasion of Ukraine, drought in South America, and Covid lockdowns in China. Both winter and spring wheat have experienced weather disruptions as well, with a drought in Kansas affecting the winter crop, and wet weather affecting the spring crop planted in April and May. Recent corn market strength would seem to argue for stepped-up plantings, but prices for nitrogen fertilizer and other key crop inputs have soared as well.

“The Craziest Year”

Reese Ivers, who farms near St. Francisville, Ill., said the mix of external factors and risks have made this the most unusual year that he can recall. "This has been the craziest year, with so much going on in the world now,” Ivers said. “Prices are so high, and we’ve seen shortages of key supplies. We’re just in unpredictable times. If we have a drought this summer, watch out.” High grain prices at this time of year may seem like a slam-dunk for farmers, but it’s not that simple. Many are reluctant to forward-sell any expected production this far in advance, considering the risks that drought or another adverse event could rob them of bushels. For farmers, 2022’s confluence of geopolitical turmoil and weather extremes reinforces the importance of nimble hedging and marketing strategies that account for fast-shifting risk considerations. Strong growth in CME Group's short-dated new-crop options, for example, illustrates the agriculture industry’s embrace of hedging tools that can be tailored around expected news (such as USDA reports), as well as the unexpected.

Graphic: Short Dated New Crop Option ADV & Open Interest (Jan-May)

So far in 2022, U.S. farmers' planting decisions have been driven largely by the availability of and costs for crop inputs, such as fertilizer, said Matt Huston, a broker with New Frontier Capital Markets in Chicago. “Corn still pencils out better than soybeans in most areas, but a lack of nitrogen fertilizer has forced some farmers to plant more soybeans or turn to other crops,” Huston said.

The following are a few key risks for U.S. agriculture during the upcoming growing season, including some real use cases for short-dated new-crop options.

USDA’s Acreage Update June 30

The U.S. Department of Agriculture, in its Prospective Plantings report on March 31, projected U.S. soybean plantings at an unexpectedly large 90.96 million acres, up 4.3% from 2021 and a record high. Corn plantings were estimated at 89.49 million acres, down 4.1% from last year and a seven-year low.

The report’s figures were based on farmer surveys conducted earlier that month, weeks before many seeds were in the ground. Since then, corn futures rallied as soggy Midwest weather delayed planting and raised prospects that some farmers may shift acres to soybeans.

With corn and soybean plantings still in flux, the USDA’s annual Acreage report at the end of June looms as a key event that will help set the tone for grain markets for much of summer.

The soybean-corn price ratio, a widely followed gauge of producers' planting inclinations, recently fell to just above 2.0, which would seem to favor more corn acres. But that may not be the case this year. The ratio's recent levels “would normally ‘buy’ a lot of corn acres, but considering input costs and availability, corn's strength versus soybeans is really just keeping the current corn acreage outlook in place,” Huston said.

Ivers, like many Midwest farmers, is planting more soybeans than corn (about 6,000 acres to the former and 5,000 to the latter). Typically, it’s the other way around. But costs for nitrogen, a key fertilizer for corn, have doubled over the past year, prompting some farmers to favor soybeans.

Weather and Yield Risks

Over the winter, drought in South America helped send corn futures above $6.00 and soybean futures above $17.00, historically high levels that may have tempted farmers to hedge at least some of their expected 2022 production. However, locking in prices before the crop is planted carries risks in any year. Drought over the summer could slash yields, for example.

Read more about short-dated new crop options.

Supply-demand dislocations such as what’s occurred in 2022 can cause a disconnect between old-crop and new-crop futures, meaning hedging new-crop production using standard put options that derive value from old-crop futures (July corn and soybean contracts, for example) won't serve as an adequate hedge, said Jack Hainline of Advance Trading Inc.

Short-dated new-crop corn and soybean options provide a workaround for such scenarios, enabling producers to secure some protection at favorable prices while still leaving open the possibility of capturing benefits from an extended rally.

In one example, Hainline said some of his clients bought July short-dated $5.40 corn put options in late February that were worth 10 cents at the time. December corn was trading around $6.00; by late April, prices topped $7.50. “Those puts lost money but holding them gave us confidence to not sell corn at $6.00.”

Continuing increases in trading volume and open interest in short-dated new-crop options reflect accelerating acceptance among farmers, grain processors, and others in the ag industry. Short-Dated New Crop options open interest – the number of outstanding contracts – reached an average of 190,000 contracts in May, while April's average daily trading volume (14,071) was up 30% from the same month in 2021.

Russia-Ukraine Conflict and Other Geopolitical Disruptions

While grain prices have faded from steep, post-invasion rallies, the Russia-Ukraine war likely will keep markets on edge for the foreseeable future. Russia and Ukraine combined account for about 29% of global wheat exports and almost one-fifth of world corn exports.

Russia-Ukraine “will remain an uncertainty,” Hainline said.

Looking Ahead to 2023: Longer-Term Risks

Beyond the 2022 growing season and harvest, Huston sees energy and fertilizer as among the largest keys to U.S. farmers' production plans and income potential (fertilizer prices are linked to natural gas).

“For 2023, we are watching natural gas prices as an indicator of availability of nitrogen,” Huston said. “Cheaper natural gas prices could open up more production, but with current prices and supply chain disruptions, fertilizer suppliers cannot guarantee supply or price it to farmers. Russia being a big fertilizer supplier throws another kink in the chain.”

High grain prices won't stay high forever, Hainline added, meaning it's critical for farmers to consider hedging opportunities now.

“We’re actively looking ahead to 2023 and what tools we can use to hedge that crop,” Hainline said. “This has been a nice bull run in commodities. But the producer who comes out ahead isn’t the one who sold the last 10% of his 2021 corn crop at $8. It's the producer who has 2022 and 2023 hedged for if and when the market moves lower. We’re thinking about multiple crop years at one time.”

Ivers is pleased to see grain prices at levels that should generate favorable profit margins for farmers this year, but he’s also concerned about an inevitable market downturn – the best cure for high prices is high prices, as one old farmer saying goes. He, too, has an eye to 2023, noting he’s concerned about securing ample supplies of fertilizer and other inputs.

Current corn and soybean prices “are enticing,” Ivers said. “But you can’t overdo it either with your new-crop sales because there are no guarantees how much you’ll get. And there’s no weather factored into the markets, either. We could still have a drought. It’s all very unpredictable.”

Read more articles like this at OpenMarkets

Read More

Continue Reading

International

Analyst reviews Apple stock price target amid challenges

Here’s what could happen to Apple shares next.

Published

on

They said it was bound to happen.

It was Jan. 11, 2024 when software giant Microsoft  (MSFT)  briefly passed Apple  (AAPL)  as the most valuable company in the world.

Microsoft's stock closed 0.5% higher, giving it a market valuation of $2.859 trillion. 

It rose as much as 2% during the session and the company was briefly worth $2.903 trillion. Apple closed 0.3% lower, giving the company a market capitalization of $2.886 trillion. 

"It was inevitable that Microsoft would overtake Apple since Microsoft is growing faster and has more to benefit from the generative AI revolution," D.A. Davidson analyst Gil Luria said at the time, according to Reuters.

The two tech titans have jostled for top spot over the years and Microsoft was ahead at last check, with a market cap of $3.085 trillion, compared with Apple's value of $2.684 trillion.

Analysts noted that Apple had been dealing with weakening demand, including for the iPhone, the company’s main source of revenue. 

Demand in China, a major market, has slumped as the country's economy makes a slow recovery from the pandemic and competition from Huawei.

Sales in China of Apple's iPhone fell by 24% in the first six weeks of 2024 compared with a year earlier, according to research firm Counterpoint, as the company contended with stiff competition from a resurgent Huawei "while getting squeezed in the middle on aggressive pricing from the likes of OPPO, vivo and Xiaomi," said senior Analyst Mengmeng Zhang.

“Although the iPhone 15 is a great device, it has no significant upgrades from the previous version, so consumers feel fine holding on to the older-generation iPhones for now," he said.

A man scrolling through Netflix on an Apple iPad Pro. Photo by Phil Barker/Future Publishing via Getty Images.

Future Publishing/Getty Images

Big plans for China

Counterpoint said that the first six weeks of 2023 saw abnormally high numbers with significant unit sales being deferred from December 2022 due to production issues.

Apple is planning to open its eighth store in Shanghai – and its 47th across China – on March 21.

Related: Tech News Now: OpenAI says Musk contract 'never existed', Xiaomi's EV, and more

The company also plans to expand its research centre in Shanghai to support all of its product lines and open a new lab in southern tech hub Shenzhen later this year, according to the South China Morning Post.

Meanwhile, over in Europe, Apple announced changes to comply with the European Union's Digital Markets Act (DMA), which went into effect last week, Reuters reported on March 12.

Beginning this spring, software developers operating in Europe will be able to distribute apps to EU customers directly from their own websites instead of through the App Store.

"To reflect the DMA’s changes, users in the EU can install apps from alternative app marketplaces in iOS 17.4 and later," Apple said on its website, referring to the software platform that runs iPhones and iPads. 

"Users will be able to download an alternative marketplace app from the marketplace developer’s website," the company said.

Apple has also said it will appeal a $2 billion EU antitrust fine for thwarting competition from Spotify  (SPOT)  and other music streaming rivals via restrictions on the App Store.

The company's shares have suffered amid all this upheaval, but some analysts still see good things in Apple's future.

Bank of America Securities confirmed its positive stance on Apple, maintaining a buy rating with a steady price target of $225, according to Investing.com

The firm's analysis highlighted Apple's pricing strategy evolution since the introduction of the first iPhone in 2007, with initial prices set at $499 for the 4GB model and $599 for the 8GB model.

BofA said that Apple has consistently launched new iPhone models, including the Pro/Pro Max versions, to target the premium market. 

Analyst says Apple selloff 'overdone'

Concurrently, prices for previous models are typically reduced by about $100 with each new release. 

This strategy, coupled with installment plans from Apple and carriers, has contributed to the iPhone's installed base reaching a record 1.2 billion in 2023, the firm said.

More Tech Stocks:

Apple has effectively shifted its sales mix toward higher-value units despite experiencing slower unit sales, BofA said.

This trend is expected to persist and could help mitigate potential unit sales weaknesses, particularly in China. 

BofA also noted Apple's dominance in the high-end market, maintaining a market share of over 90% in the $1,000 and above price band for the past three years.

The firm also cited the anticipation of a multi-year iPhone cycle propelled by next-generation AI technology, robust services growth, and the potential for margin expansion.

On Monday, Evercore ISI analysts said they believed that the sell-off in the iPhone maker’s shares may be “overdone.”

The firm said that investors' growing preference for AI-focused stocks like Nvidia  (NVDA)  has led to a reallocation of funds away from Apple. 

In addition, Evercore said concerns over weakening demand in China, where Apple may be losing market share in the smartphone segment, have affected investor sentiment.

And then ongoing regulatory issues continue to have an impact on investor confidence in the world's second-biggest company.

“We think the sell-off is rather overdone, while we suspect there is strong valuation support at current levels to down 10%, there are three distinct drivers that could unlock upside on the stock from here – a) Cap allocation, b) AI inferencing, and c) Risk-off/defensive shift," the firm said in a research note.

Related: Veteran fund manager picks favorite stocks for 2024

Read More

Continue Reading

International

Major typhoid fever surveillance study in sub-Saharan Africa indicates need for the introduction of typhoid conjugate vaccines in endemic countries

There is a high burden of typhoid fever in sub-Saharan African countries, according to a new study published today in The Lancet Global Health. This high…

Published

on

There is a high burden of typhoid fever in sub-Saharan African countries, according to a new study published today in The Lancet Global Health. This high burden combined with the threat of typhoid strains resistant to antibiotic treatment calls for stronger prevention strategies, including the use and implementation of typhoid conjugate vaccines (TCVs) in endemic settings along with improvements in access to safe water, sanitation, and hygiene.

Credit: IVI

There is a high burden of typhoid fever in sub-Saharan African countries, according to a new study published today in The Lancet Global Health. This high burden combined with the threat of typhoid strains resistant to antibiotic treatment calls for stronger prevention strategies, including the use and implementation of typhoid conjugate vaccines (TCVs) in endemic settings along with improvements in access to safe water, sanitation, and hygiene.

 

The findings from this 4-year study, the Severe Typhoid in Africa (SETA) program, offers new typhoid fever burden estimates from six countries: Burkina Faso, Democratic Republic of the Congo (DRC), Ethiopia, Ghana, Madagascar, and Nigeria, with four countries recording more than 100 cases for every 100,000 person-years of observation, which is considered a high burden. The highest incidence of typhoid was found in DRC with 315 cases per 100,000 people while children between 2-14 years of age were shown to be at highest risk across all 25 study sites.

 

There are an estimated 12.5 to 16.3 million cases of typhoid every year with 140,000 deaths. However, with generic symptoms such as fever, fatigue, and abdominal pain, and the need for blood culture sampling to make a definitive diagnosis, it is difficult for governments to capture the true burden of typhoid in their countries.

 

“Our goal through SETA was to address these gaps in typhoid disease burden data,” said lead author Dr. Florian Marks, Deputy Director General of the International Vaccine Institute (IVI). “Our estimates indicate that introduction of TCV in endemic settings would go to lengths in protecting communities, especially school-aged children, against this potentially deadly—but preventable—disease.”

 

In addition to disease incidence, this study also showed that the emergence of antimicrobial resistance (AMR) in Salmonella Typhi, the bacteria that causes typhoid fever, has led to more reliance beyond the traditional first line of antibiotic treatment. If left untreated, severe cases of the disease can lead to intestinal perforation and even death. This suggests that prevention through vaccination may play a critical role in not only protecting against typhoid fever but reducing the spread of drug-resistant strains of the bacteria.

 

There are two TCVs prequalified by the World Health Organization (WHO) and available through Gavi, the Vaccine Alliance. In February 2024, IVI and SK bioscience announced that a third TCV, SKYTyphoid™, also achieved WHO PQ, paving the way for public procurement and increasing the global supply.

 

Alongside the SETA disease burden study, IVI has been working with colleagues in three African countries to show the real-world impact of TCV vaccination. These studies include a cluster-randomized trial in Agogo, Ghana and two effectiveness studies following mass vaccination in Kisantu, DRC and Imerintsiatosika, Madagascar.

 

Dr. Birkneh Tilahun Tadesse, Associate Director General at IVI and Head of the Real-World Evidence Department, explains, “Through these vaccine effectiveness studies, we aim to show the full public health value of TCV in settings that are directly impacted by a high burden of typhoid fever.” He adds, “Our final objective of course is to eliminate typhoid or to at least reduce the burden to low incidence levels, and that’s what we are attempting in Fiji with an island-wide vaccination campaign.”

 

As more countries in typhoid endemic countries, namely in sub-Saharan Africa and South Asia, consider TCV in national immunization programs, these data will help inform evidence-based policy decisions around typhoid prevention and control.

 

###

 

About the International Vaccine Institute (IVI)
The International Vaccine Institute (IVI) is a non-profit international organization established in 1997 at the initiative of the United Nations Development Programme with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health.

IVI’s current portfolio includes vaccines at all stages of pre-clinical and clinical development for infectious diseases that disproportionately affect low- and middle-income countries, such as cholera, typhoid, chikungunya, shigella, salmonella, schistosomiasis, hepatitis E, HPV, COVID-19, and more. IVI developed the world’s first low-cost oral cholera vaccine, pre-qualified by the World Health Organization (WHO) and developed a new-generation typhoid conjugate vaccine that is recently pre-qualified by WHO.

IVI is headquartered in Seoul, Republic of Korea with a Europe Regional Office in Sweden, a Country Office in Austria, and Collaborating Centers in Ghana, Ethiopia, and Madagascar. 39 countries and the WHO are members of IVI, and the governments of the Republic of Korea, Sweden, India, Finland, and Thailand provide state funding. For more information, please visit https://www.ivi.int.

 

CONTACT

Aerie Em, Global Communications & Advocacy Manager
+82 2 881 1386 | aerie.em@ivi.int


Read More

Continue Reading

International

US Spent More Than Double What It Collected In February, As 2024 Deficit Is Second Highest Ever… And Debt Explodes

US Spent More Than Double What It Collected In February, As 2024 Deficit Is Second Highest Ever… And Debt Explodes

Earlier today, CNBC’s…

Published

on

US Spent More Than Double What It Collected In February, As 2024 Deficit Is Second Highest Ever... And Debt Explodes

Earlier today, CNBC's Brian Sullivan took a horse dose of Red Pills when, about six months after our readers, he learned that the US is issuing $1 trillion in debt every 100 days, which prompted him to rage tweet, (or rageX, not sure what the proper term is here) the following:

We’ve added 60% to national debt since 2018. Germany - a country with major economic woes - added ‘just’ 32%.   

Maybe it will never matter.   Maybe MMT is real.   Maybe we just cancel or inflate it out. Maybe career real estate borrowers or career politicians aren’t the answer.

I have no idea.  Only time will tell.   But it’s going to be fascinating to watch it play out.

He is right: it will be fascinating, and the latest budget deficit data simply confirmed that the day of reckoning will come very soon, certainly sooner than the two years that One River's Eric Peters predicted this weekend for the coming "US debt sustainability crisis."

According to the US Treasury, in February, the US collected $271 billion in various tax receipts, and spent $567 billion, more than double what it collected.

The two charts below show the divergence in US tax receipts which have flatlined (on a trailing 6M basis) since the covid pandemic in 2020 (with occasional stimmy-driven surges)...

... and spending which is about 50% higher compared to where it was in 2020.

The end result is that in February, the budget deficit rose to $296.3 billion, up 12.9% from a year prior, and the second highest February deficit on record.

And the punchline: on a cumulative basis, the budget deficit in fiscal 2024 which began on October 1, 2023 is now $828 billion, the second largest cumulative deficit through February on record, surpassed only by the peak covid year of 2021.

But wait there's more: because in a world where the US is spending more than twice what it is collecting, the endgame is clear: debt collapse, and while it won't be tomorrow, or the week after, it is coming... and it's also why the US is now selling $1 trillion in debt every 100 days just to keep operating (and absorbing all those millions of illegal immigrants who will keep voting democrat to preserve the socialist system of the US, so beloved by the Soros clan).

And it gets even worse, because we are now in the ponzi finance stage of the Minsky cycle, with total interest on the debt annualizing well above $1 trillion, and rising every day

... having already surpassed total US defense spending and soon to surpass total health spending and, finally all social security spending, the largest spending category of all, which means that US debt will now rise exponentially higher until the inevitable moment when the US dollar loses its reserve status and it all comes crashing down.

We conclude with another observation by CNBC's Brian Sullivan, who quotes an email by a DC strategist...

.. which lays out the proposed Biden budget as follows:

The budget deficit will growth another $16 TRILLION over next 10 years. Thats *with* the proposed massive tax hikes.

Without them the deficit will grow $19 trillion.

That's why you will hear the "deficit is being reduced by $3 trillion" over the decade.

No family budget or business could exist with this kind of math.

Of course, in the long run, neither can the US... and since neither party will ever cut the spending which everyone by now is so addicted to, the best anyone can do is start planning for the endgame.

Tyler Durden Tue, 03/12/2024 - 18:40

Read More

Continue Reading

Trending